Dr. Samarth Lakshmaiah Reddy, MD

Dr. Reddy practices at Florida Cancer Specialists & Research Institute - Cape Coral Cay West in Cape Coral, Florida.

Dr. Reddy's NPI, 1851389514, was assigned on October 7, 2005. Dr. Reddy graduated from Wayne State University School Of Medicine in 1996. Dr. Reddy holds Florida license ME87684.

Dr. Reddy's primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West, at 1708 Cape Coral W Pkwy, Cape Coral, FL 33914 in Lee County. The practice phone is (239) 541-4633.

Dr. Reddy's primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West in Cape Coral, Florida. Dr. Reddy is also affiliated with Boca Raton Regional Hospital. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Reddy to 2 more hospitals, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reddy practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Reddy's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Reddy is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Reddy's licenses on file in 2 states: Florida and Illinois.

Dmand AI lists arterial blot clot /embolism, chronic anemia, chronic leukemia, deep vein thrombosis (DVT), immune deficiency disease, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Reddy treats.

CMS data shows 98,265 Medicare services from Dr. Reddy across 41 procedure codes in 2024, for 856 Medicare patients. Medicare paid $2,734,296 for them. Every service was in an office.

CMS counts 856 Medicare patients who saw Dr. Reddy in 2024. The largest group is 75 to 84, with 385 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Reddy's median patient age at 72, with 55% women.

In 2024, Dr. Reddy wrote 1,683 Medicare Part D claims for 338 patients. 76% of them were for generic drugs. CMS names the drug for 1,451 of them, across 32 drugs with 11 or more claims each, at $4,545,175 in total drug cost. In 2023, CMS named 938 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Reddy for performance year 2024, reported as part of a group. Dr. Reddy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Reddy as offering telehealth.

Dmand AI links 2 papers to Dr. Reddy in 2020. 2020 was the busiest year, with 2. Dr. Reddy's most frequent co-authors are Shelbie Cole, DO, Gerardo Colon-Otero, MD and Ryder Lane Costa, DO.

CMS Open Payments shows 779 general payments to Dr. Reddy from 71 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Janssen Pharmaceuticals, Inc paid the most, $2,218.

Dmand AI lists 2 awards for Dr. Reddy, most recently Regional Top Doctor in 2014.

Dr. Reddy graduated from Wayne State University School Of Medicine in 1996.

Dr. Reddy is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.